Hanna, M. H., Askenazi, D. J. & Selewski, D. T. Drug-induced acute kidney injury in neonates. Curr. Opin. Pediatr. 28, 180–187 (2016).
Selewski, D. T. et al. Neonatal acute kidney injury. Pediatrics 136, e463–e473 (2015).
Kent, A. L. et al. Renal glomeruli and tubular injury following indomethacin, ibuprofen, and gentamicin exposure in a neonatal rat model. Pediatr. Res. 62, 307–312 (2007).
Schreuder, M. F. et al. Effect of drugs on renal development. Clin. J. Am. Soc. Nephrol. 6, 212–217 (2011).
Ohlsson, A., Walia, R. & Shah S. S. Ibuprofen for the treatment of patent ductus arteriosus in preterm or low birth weight (or both) infants. Cochrane Database Syst. Rev. Issue 2. Art. No.: CD003481 (2015).
Bateman, D. A. et al. Serum creatinine concentration in very-low-birth-weight infants from birth to 34–36 wk postmenstrual age. Pediatr. Res. 77, 696–702 (2015).
Guignard, J. P. & Drukker, A. Why do newborn infants have a high plasma creatinine? Pediatrics 103, e49 (1999).
McCaffrey, J., Dhakal, A. K., Milford, D. V., Webb, N. J. & Lennon, R. Recent developments in the detection and management of acute kidney injury. Arch. Dis. Child. 102, 91–96 (2017).
Schrezenmeier, E. V., Barasch, J., Budde, K., Westhoff, T. & Schmidt-Ott, K. M. Biomarkers in acute kidney injury—pathophysiological basis and clinical performance. Acta Physiol. (Oxf.). 219, 554–572 (2017).
Askenazi, D. J. et al. Acute kidney injury urine biomarkers in very low-birth-weight infants. Clin. J. Am. Soc. Nephrol. 11, 1527–1535 (2016).
Genc, G., Ozkaya, O., Avci, B., Aygun, C. & Kucukoduk, S. Kidney injury molecule-1 as a promising biomarker for acute kidney injury in premature babies. Am. J. Perinatol. 30, 245–252 (2013).
Lavery, A. P. et al. Urinary NGAL in premature infants. Pediatr. Res. 64, 423–428 (2008).
Sarafidis, K. et al. Urine neutrophil gelatinase-associated lipocalin to predict acute kidney injury in preterm neonates. A pilot study. Pediatr. Nephrol. 29, 305–310 (2014).
Tabel, Y. et al. Urinary neutrophil gelatinase-associated lipocalin as an early biomarker for prediction of acute kidney injury in preterm infants. Am. J. Perinatol. 31, 167–174 (2014).
Sweetman, D. U. Neonatal acute kidney injury—severity and recovery prediction and the role of serum and urinary biomarkers. Early Hum. Dev. 105, 57–61 (2017).
Heller, F., Frischmann, S., Grunbaum, M., Zidek, W. & Westhoff, T. H. Urinary calprotectin and the distinction between prerenal and intrinsic acute kidney injury. Clin. J. Am. Soc. Nephrol. 6, 2347–2355 (2011).
Westhoff, J. H. et al. Urinary biomarkers for the differentiation of prerenal and intrinsic pediatric acute kidney injury. Pediatr. Nephrol. 31, 2353–2363 (2016).
Vijayan, A. et al. Clinical use of the urine biomarker [TIMP-2] x [IGFBP7] for acute kidney injury risk assessment. Am. J. Kidney Dis. 68, 19–28 (2016).
Sperandio, M. et al. Effectiveness and side effects of an escalating, stepwise approach to indomethacin treatment for symptomatic patent ductus arteriosus in premature infants below 33 weeks of gestation. Pediatrics 116, 1361–1366 (2005).
Kellum, J. A., Lameire, N. & Group KAGW. Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1). Crit. Care 17, 204 (2013).
Westhoff, J. H. et al. Urinary tissue inhibitor of metalloproteinase-2 (TIMP-2) * insulin-like growth factor-binding protein 7 (IGFBP7) predicts adverse outcome in pediatric acute kidney injury. PLoS ONE 10, e0143628 (2015).
Seibert, F. S. et al. Calprotectin and neutrophil gelatinase-associated lipocalin in the differentiation of pre-renal and intrinsic acute kidney injury. Acta Physiol. (Oxf.). 207, 700–708 (2013).
Akima, S., Kent, A., Reynolds, G. J., Gallagher, M. & Falk, M. C. Indomethacin and renal impairment in neonates. Pediatr. Nephrol. 19, 490–493 (2004).
Haase, M. et al. The outcome of neutrophil gelatinase-associated lipocalin-positive subclinical acute kidney injury: a multicenter pooled analysis of prospective studies. J. Am. Coll. Cardiol. 57, 1752–1761 (2011).
Allegaert, K., De Hoon, J., Debeer, A. & Gewillig, M. Renal side effects of non-steroidal anti-inflammatory drugs in neonates. Pharmaceuticals (Basel) 3, 393–405 (2010).
Kashani, K. et al. Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury. Crit. Care 17, R25 (2013).
Kuribayashi, R. et al. Urinary neutrophil gelatinase-associated lipocalin is an early predictor of acute kidney injury in premature infants. Exp. Ther. Med. 12, 3706–3710 (2016).
Parravicini, E. The clinical utility of urinary neutrophil gelatinase-associated lipocalin in the neonatal ICU. Curr. Opin. Pediatr. 22, 146–150 (2010).
Sellmer, A. et al. Urinary neutrophil gelatinase-associated lipocalin in the evaluation of patent ductus arteriosus and AKI in very preterm neonates: a cohort study. BMC Pediatr. 17, 7 (2017).
Tosse, V. et al. Urinary NT-proBNP, NGAL, and H-FABP may predict hemodynamic relevance of patent ductus arteriosus in very low birth weight infants. Neonatology 101, 260–266 (2012).
Fujiu, K., Manabe, I. & Nagai, R. Renal collecting duct epithelial cells regulate inflammation in tubulointerstitial damage in mice. J. Clin. Invest. 121, 3425–3441 (2011).
Dessing, M. C. et al. The calcium-binding protein complex S100A8/A9 has a crucial role in controlling macrophage-mediated renal repair following ischemia/reperfusion. Kidney Int. 87, 85–94 (2015).
McCullough, P. A. et al. Diagnosis of acute kidney injury using functional and injury biomarkers: workgroup statements from the tenth Acute Dialysis Quality Initiative Consensus Conference. Contrib. Nephrol. 182, 13–29 (2013).
Endre, Z. H. et al. Differential diagnosis of AKI in clinical practice by functional and damage biomarkers: workgroup statements from the tenth Acute Dialysis Quality Initiative Consensus Conference. Contrib. Nephrol. 182, 30–44 (2013).
Lee, B. S. et al. Effect of furosemide on ductal closure and renal function in indomethacin-treated preterm infants during the early neonatal period. Neonatology 98, 191–199 (2010).
Fiseha, T. & Tamir, Z. Urinary markers of tubular injury in early diabetic nephropathy. Int. J. Nephrol. 2016, 4647685 (2016).
Koralkar, R. et al. Acute kidney injury reduces survival in very low birth weight infants. Pediatr. Res. 69, 354–358 (2011).
Parry, G., Tucker, J., Tarnow-Mordi, W. & Group UKNSSC. CRIB II: an update of the clinical risk index for babies score. Lancet 361, 1789–1791 (2003).
Huynh, T. K. et al. Reference values of urinary neutrophil gelatinase-associated lipocalin in very low birth weight infants. Pediatr. Res. 66, 528–532 (2009).
Vinall, J. & Grunau, R. E. Impact of repeated procedural pain-related stress in infants born very preterm. Pediatr. Res. 75, 584–587 (2014).